Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease

Published:2023-07-19 Issue:7 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Cooper Tess E¹,Teng Claris²,Tunnicliffe David J¹,Cashmore Brydee A³,Strippoli Giovanni FM¹⁴⁵

Affiliation:

1. Sydney School of Public Health; The University of Sydney; Sydney Australia

2. Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

3. Centre for Kidney Research; The University of Sydney and The Children's Hospital at Westmead; Sydney Australia

4. Department of Emergency and Organ Transplantation; University of Bari; Bari Italy

5. Cochrane Kidney and Transplant; Centre for Kidney Research, The Children's Hospital at Westmead; Westmead Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference381 articles.

1. Effect of benazepril in chronic renal insufficiency;Apperloo;New England Journal of Medicine,1996

2. Effect of benazepril in chronic renal insufficiency;Curren;New England Journal of Medicine,1996

3. Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation;Hogan;Pharmacoeconomics,2002

4. Long-term progression of chronic renal insufficiency in the AIPRI extension study. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group;Locatelli;Kidney International - Supplement,1997

5. The role of underlying nephropathy in the progression of renal disease;Locatelli;Kidney International - Supplement,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. For adults with early (stages 1 to 3) nondiabetic chronic kidney disease, how do angiotensin-converting enzyme inhibitors (ACEi) compare with placebo?;Cochrane Clinical Answers;2024-05-23

2. Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets;Journal of Clinical Medicine;2024-03-25